RETRO Study (RETrograde Renal Access Outcomes)

Part of paid clinical trials in Tampa, Florida.

Sponsor
University of Kansas Medical Center
Study ID
NCT07071831
Status
Recruiting
Apply to this trial

Conditions

  • Renal Stones

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • RetroPerc® — DEVICE
    The RetroPerc® will be used to obtain renal access.

Study Details

The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous nephrolithotomy as part of their regular care will be asked to participate.

Key Dates

Start date
Dec 6, 2024
Status verified
May 2026
Primary completion
Apr 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Percutaneous Nephrolithotomy
    Participants with a single renal stone or total sum of 1.5 to 3 cm in maximum dimension of multiple stones undergoing percutaneous nephrolithotomy as part of their routine medical care using the RetroPerc® system to obtain renal access.

Primary Outcome Measure

Proportion of successful renal access per access attempts [ Time Frame: Procedure ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of South FloridaTampaFlorida33606
Renya Maku
[email protected]
813-821-8035
David Hernandez, MD (PRINCIPAL_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66105
Research Program Manager
[email protected]
913-588-8721
Bristol Whiles, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tampa, FL

By research site
University of South Florida· Tampa, FLUniversity of Kansas Medical Center· Kansas City, KS

Related Studies